Quintiles Transitional Holdings Inc. (NYSE:Q) – Stock analysts at SunTrust Banks increased their FY2017 earnings per share (EPS) estimates for shares of Quintiles Transitional Holdings in a research report issued to clients and investors on Wednesday. SunTrust Banks analyst S. Draper now forecasts that the medical research company will earn $4.60 per share for the year, up from their previous forecast of $4.55. SunTrust Banks has a “Hold” rating and a $114.00 price target on the stock. SunTrust Banks also issued estimates for Quintiles Transitional Holdings’ FY2018 earnings at $5.48 EPS and FY2019 earnings at $6.48 EPS.

Other research analysts have also recently issued research reports about the company. Zacks Investment Research raised Quintiles Transitional Holdings from a “hold” rating to a “buy” rating and set a $101.00 price objective on the stock in a research report on Thursday, July 27th. Barclays PLC set a $100.00 price objective on Quintiles Transitional Holdings and gave the stock a “buy” rating in a research report on Friday, August 4th. BidaskClub cut Quintiles Transitional Holdings from a “strong-buy” rating to a “buy” rating in a research report on Friday, August 11th. Argus upped their price target on Quintiles Transitional Holdings from $98.00 to $104.00 and gave the company a “buy” rating in a research report on Monday, September 18th. Finally, KeyCorp reaffirmed a “buy” rating and set a $100.00 price target on shares of Quintiles Transitional Holdings in a research report on Sunday, September 24th. Ten equities research analysts have rated the stock with a hold rating, ten have given a buy rating and one has given a strong buy rating to the company’s stock. Quintiles Transitional Holdings presently has an average rating of “Buy” and a consensus price target of $102.33.

COPYRIGHT VIOLATION NOTICE: “FY2017 Earnings Forecast for Quintiles Transitional Holdings Inc. (Q) Issued By SunTrust Banks” was reported by American Banking News and is owned by of American Banking News. If you are reading this news story on another domain, it was copied illegally and republished in violation of U.S. & international copyright & trademark law. The original version of this news story can be read at https://www.americanbankingnews.com/2017/11/06/fy2017-earnings-forecast-for-quintiles-transitional-holdings-inc-q-issued-by-suntrust-banks.html.

Quintiles Transitional Holdings (NYSE:Q) opened at $108.02 on Monday. The company has a debt-to-equity ratio of 1.29, a current ratio of 1.22 and a quick ratio of 1.23. Quintiles Transitional Holdings has a 1 year low of $71.90 and a 1 year high of $109.00. The firm has a market capitalization of $22,826.14, a price-to-earnings ratio of 24.66, a price-to-earnings-growth ratio of 1.79 and a beta of 0.65.

Quintiles Transitional Holdings (NYSE:Q) last posted its quarterly earnings data on Thursday, October 26th. The medical research company reported $1.19 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $1.14 by $0.05. Quintiles Transitional Holdings had a return on equity of 12.60% and a net margin of 0.58%. The business had revenue of $2.02 billion for the quarter, compared to analysts’ expectations of $2.01 billion. During the same quarter in the previous year, the firm earned $1.00 earnings per share. The business’s revenue was up 77.6% on a year-over-year basis.

In related news, insider Kevin C. Knightly sold 19,339 shares of the business’s stock in a transaction on Friday, August 25th. The stock was sold at an average price of $99.51, for a total transaction of $1,924,423.89. Following the sale, the insider now directly owns 40,650 shares in the company, valued at approximately $4,045,081.50. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, major shareholder Cpp Investment Board Private H sold 6,748,026 shares of the business’s stock in a transaction on Tuesday, September 19th. The shares were sold at an average price of $94.87, for a total value of $640,185,226.62. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 14,162,302 shares of company stock worth $1,359,495,910. 6.40% of the stock is currently owned by corporate insiders.

Hedge funds and other institutional investors have recently made changes to their positions in the business. Fiduciary Trust Co. bought a new position in Quintiles Transitional Holdings in the 2nd quarter worth about $105,000. GWM Advisors LLC bought a new position in Quintiles Transitional Holdings in the 2nd quarter worth about $122,000. Korea Investment CORP increased its stake in Quintiles Transitional Holdings by 142.5% in the 2nd quarter. Korea Investment CORP now owns 1,370 shares of the medical research company’s stock worth $123,000 after acquiring an additional 805 shares during the last quarter. Citigroup Inc. increased its stake in Quintiles Transitional Holdings by 15.5% in the 2nd quarter. Citigroup Inc. now owns 1,858 shares of the medical research company’s stock worth $167,000 after acquiring an additional 250 shares during the last quarter. Finally, Bbva Compass Bancshares Inc. increased its stake in Quintiles Transitional Holdings by 4.2% in the 2nd quarter. Bbva Compass Bancshares Inc. now owns 2,204 shares of the medical research company’s stock worth $197,000 after acquiring an additional 88 shares during the last quarter. Institutional investors and hedge funds own 93.03% of the company’s stock.

Quintiles Transitional Holdings Company Profile

Quintiles IMS Holdings, Inc, formerly Quintiles Transnational Holdings Inc, provides integrated information and technology-enabled healthcare services. The Company operates through segments, including Commercial Solutions; Research & Development Solutions, and Integrated Engagement Services. The Commercial Solutions segment offerings include national information offerings, sub-national information offerings, technology solutions, and workflow analytics and consulting services.

Earnings History and Estimates for Quintiles Transitional Holdings (NYSE:Q)

Receive News & Ratings for Quintiles Transitional Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Quintiles Transitional Holdings Inc. and related companies with MarketBeat.com's FREE daily email newsletter.